If you’ve scheduled or are considering your first SPRAVATO® treatment session, it’s completely normal to feel nervous. Most people aren’t afraid of the medication itself— they’re afraid of the unknown: What will it feel like? Will I be “out of it”? What if I panic? How long will I be there?
This post is designed to reduce that uncertainty with a clear, step-by-step walkthrough of what typically happens during a first session at a certified clinic like EverHope. It’s educational, realistic, and grounded in the safety requirements used across SPRAVATO® treatment centers.
Why SPRAVATO® sessions are done in-clinic
SPRAVATO® (or esketamine) is sometimes described alongside traditional ketamine therapy because it comes from the same medication family, but the care model varies slightly.
Since SPRAVATO® is an FDA-approved product, it must be administered in a certified healthcare setting under a restricted safety program called the SPRAVATO® REMS (Risk Evaluation and Mitigation Strategy). This is because some people experience short-term side effects like sedation, dissociation, or occasionally breathing-related complications, and the clinic needs to monitor patients until they’re stable enough to leave.
The FDA prescribing standards specifies that patients must be regularly monitored for at least two hours after each administration of SPRAVATO®, followed by an assessment to confirm they’re clinically stable enough to return home.
Before Your First Session: How to Prepare
The best first sessions are the ones where logistics are handled ahead of time, so you can focus on being present and comfortable.
Most clinics will help you remember preparation details like your ride home and what you can eat beforehand. SPRAVATO® can cause nausea for some people, so many centers recommend a lighter meal and simple hydration habits before arriving.
What you’ll likely want to bring is anything to help you remain calm and comfortable. Many patients choose to bring a jacket or blanket, headphones, and eye mask and prepare a playlist of calming music or nature sounds. Your goal is not to “perform wellness,” but to make the environment easy on your nervous system.
Most importantly, remember to coordinate transportation. You cannot drive yourself home after treatment.
Step-By-Step: What Happens During a First SPRAVATO® Session
Your first appointment is typically the most “structured,” because the team is establishing a baseline and making sure you know what to expect.
Step 1: Check-in for a brief medical screening
You’ll check in, review any necessary consent paperwork, and the clinical team may ask about how you’re feeling that day. You’ll also have vital signs checked, especially blood pressure as esketamine can occasionally cause a temporary rise in blood pressure after dosing.
If you have questions or concerns like, “Will this interact with my meds?” or “I’m anxious about dissociation,” this is a good moment to say it out loud. We expect questions and nerves, especially on visit one.
Step 2: Get settled in the treatment room
You’ll be brought to a comfortable area with a couch or reclining chair where you can sit back and relax during the monitoring window. Many people find it helpful to choose a low-stimulation plan like listening to a playlist and keeping eyes closed. Some people prefer gentle conversation or meditative practices; others prefer quiet. Both are normal.
Because it’s your first session, your team may also explain how they monitor you and what symptoms to report immediately (for example, chest pain, sudden severe headache, shortness of breath, or significant distress).
Step 3: Administration of the nasal spray
SPRAVATO® is intended for patient self-administration, but it happens under direct observation of a healthcare provider. Your clinician will guide you through timing and technique, and they’ll remain available throughout the session.
Many patients worry here that they’ll “do it wrong.” In reality, clinics do this every day. You are not expected to be an expert at your own first appointment.
Step 4: The monitoring period
After dosing, you’ll stay in the clinic’s calming treatment room for observation for about two hours. During this time, the team monitors for known risks such as sedation and extreme dissociation.
This is also when people tend to ask, “What should I be doing?” There’s no single right answer, but it’s common to simply rest quietly, listen to music and let your brain be still for a moment. SPRAVATO® isn’t about forcing insight but about giving your brain the conditions to detach and respond differently over time.
Step 5: Discharge and ride home
At the end of monitoring, the team will check how you’re feeling and decide when you’re clinically stable to go. You’ll leave with your ride and plan for a lighter day afterward. Remember: no driving, heavy or hazardous activities until the next day after restful sleep.
What it can feel like (and what’s normal)
People often want to know what SPRAVATO® “feels like,” and the honest answer is: it varies.
Some patients feel sleepy or “floaty.” Some feel emotionally neutral. Many experience dissociation—often described as feeling slightly detached from your body, or like time and space feel different. This is one reason monitoring exists, and it’s also why many clinics encourage calming input (music, eyes closed, low stimulation). The medication can also cause dizziness or lightheadedness for some people, which typically improves as the session progresses.
If you’re worried about panic, tell your care team. Fear is very normal and a safety plan exists to help you get through your session. You don’t have to “white-knuckle” through the experience.
How quickly will you feel better?
SPRAVATO® is often discussed as a faster-acting option compared to standard antidepressants, and clinical trials support meaningful symptom reduction for many patients with treatment-resistant depression when used alongside, or replacing, an oral antidepressant.
Some people feel a noticeable shift early, some feel gradual change over multiple sessions, and some need treatment adjustments. The first session is often about tolerability, safety, and establishing the routine—not putting pressure on yourself to feel instantly “fixed.”
Bigger care plans
SPRAVATO® is typically used alongside an oral antidepressant or different therapy modality and delivered as part of a structured care plan.
In practice, the most successful outcomes usually come from combining biological support with consistent follow-up, psychotherapy when appropriate, and practical changes that support stability (sleep, nutrition, stress load, connection).
SPRAVATO® may be a powerful tool, but you’re not meant to rely on a tool alone. You deserve a long-term plan.
Questions to ask at your first SPRAVATO® visit
If you’re preparing for SPRAVATO® or considering options like ketamine therapy, consider asking questions during your consultation. Some helpful clarifications could be:
- What side effects are most common in your clinic, and how do you help patients through them?
- How will you measure progress (symptoms, functioning, goals)?
- What is the recommended treatment schedule for my situation?
- What should I do on treatment days (work, childcare, rest)?
- Who do I contact if I feel worse between sessions?
These questions help you feel oriented and help the clinic tailor the plan to you.
A gentle next step
If you’re considering SPRAVATO® in Columbus, Ohio, the best next step is a consultation where you can talk through your history, what you’ve already tried, and whether SPRAVATO® fits your needs.
At EverHope, our goal is to make the first step feel less intimidating and more practical. We strive for our consultations to be a conversation, a plan, and a clear understanding of what comes next.
If you’re ready, reach out to schedule an appointment—and if you’re not ready yet, save this guide and come back when you are. You don’t have to do this alone.
References
U.S. Food and Drug Administration. (2019). SPRAVATO® (esketamine) prescribing information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211243lbl.pdf
National Institute of Mental Health. Depression — overview and treatment considerations. https://www.nimh.nih.gov/health/topics/depression
Spravato REMS Program Overview. (n.d.). Janssen Pharmaceuticals, Inc. https://www.spravatorems.com/pdfs/REMSProgramOverview
SPRAVATO® (esketamine) medical search results. (n.d.). J&J Medical Connect. https://www.jnjmedicalconnect.com/products/spravato/medical-search-results?ct=Patient+Medical+Information&q=Spravato&sp=SPRAVATO%C2%AE
